Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research focused on Percutaneous coronary intervention and Ticagrelor, with related work in Myocardial infarction, Ejection fraction, Heart failure. Notable publications include 'Prevalence and Prognosis of HFimpEF Developed From Patients With Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis', '2018 update of expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI', and 'Clinical characteristics and 1‐year outcomes in hospitalized patients with heart failure with preserved ejection fraction: results from the China Cardiovascular Association...'.
Comparative outcomes of invasive versus conservative strategy in stable coronary artery disease patients: a risk-stratification-based hypothesis-generative study
Enhancing Data Preprocessing using Positional Self-Attention Autoencoders
2023 Chinese expert consensus on the impact of COVID-19 on the management of cardiovascular diseases
Clinical characteristics and 1‐year outcomes in hospitalized patients with heart failure with preserved ejection fraction: results from the China Cardiovascular Association <scp>Database‐Heart</scp> Failure Center Registry
Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy
Trends in percutaneous coronary intervention in China: analysis of China PCI Registry Data from 2010 to 2018
Prevalence and Prognosis of HFimpEF Developed From Patients With Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis
Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial
Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
Diabetes association with self‐reported health, resource utilization, and prognosis post‐myocardial infarction
Long-term follow-up of antithrombotic management patterns in patients with acute coronary syndrome in China.
Long-term antiplatelet therapy in medically managed non-ST-segment elevation acute coronary syndromes: The EPICOR Asia study
Protocol of the China ST-segment elevation myocardial infarction (STEMI) Care Project (CSCAP): a 10-year project to improve quality of care by building up a regional STEMI care network
A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC‐ACS study
2018 update of expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI
GW26-e2411 Pre-hospital Management in Chinese Patients with Acute Coronary Syndrome: Findings from the EPICOR Asia Study